Editorial
Accepted on 09 Jul 2025
Pharmaceutical treatment of infections in internal medicine
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1650144
Type at least 3 characters
385 articles
Original Research
Accepted on 09 Jul 2025
Evaluating the Efficacy of Different Doses of Tocilizumab in Treating Critically Ill COVID-19 Patients: A Single-Center Retrospective Cohort Study
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1571372
Original Research
Published on 09 Jul 2025
The GPR4 antagonist NE-52-QQ57 increases survival, mitigates the hyperinflammatory response and reduces viral load in SARS-CoV-2-infected K18-hACE2 transgenic mice
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1549296
- 356 views
Review
Accepted on 07 Jul 2025
The Potential of Exogenous Specialized Pro-resolving Mediators in Protecting Against Sepsis-related Lung Injury: A Review
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1622754
Original Research
Published on 02 Jul 2025
Advanced therapeutic strategy for managing surgical site infections with natural nanoemulsion-antimicrobial combination
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1617184
- 251 views
Original Research
Accepted on 30 Jun 2025
Impact of Complex Interventions on Antibacterial Therapy and Etiological Diagnostics in Community-Acquired Pneumonia: A 12-Month Pre-and Post-Intervention Study
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1627858
- 121 views
Systematic Review
Published on 30 Jun 2025
Metabolic effects and cardiovascular disease risks of TDF or TAF in patients with chronic hepatitis B: a systematic review and meta-analysis
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1604972
- 366 views
Original Research
Accepted on 26 Jun 2025
Exploring the therapeutic mechanism of itraconazole combined with ritonavir on Candida albicans infection through network pharmacology and molecular docking
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1578749
- 165 views
Original Research
Accepted on 20 Jun 2025
The Role of Probiotic Supplementation in Reducing Helicobacter pylori Recurrence After Classic Quadruple Therapy
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1621090
- 163 views
Original Research
Published on 20 Jun 2025
Exploring research dynamics of PDT in anti-infective applications (2004–2024): a bibliometric perspective
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1510690
- 694 views
Correction
Published on 10 Jun 2025
Correction: Clinical pharmacist-led problem-specific education as a strategy for addressing suboptimal antimicrobial use in intensive care unit: a prospective pre-post analysis
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1637512
- 484 views
Original Research
Published on 03 Jun 2025
Therapeutic vancomycin monitoring: a comparative analysis of high-performance liquid chromatography and chemiluminescent microparticle immunoassay methods in liver transplant recipients
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1516339
- 813 views
Original Research
Published on 30 May 2025
From genomics to treatment: overcoming pan-drug-resistant Klebsiella pneumoniae in clinical settings
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1570278
- 1,226 views
Original Research
Published on 26 May 2025
Clinical pharmacist-led problem-specific education as a strategy for addressing suboptimal antimicrobial use in intensive care unit: a prospective pre-post analysis
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1556884
- 1,112 views
Original Research
Published on 15 May 2025
Bakuchiol kills Staphylococcus aureus persisters and potentiates colistin activity against Acinetobacter baumannii persisters
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1592183
- 1,186 views
Original Research
Published on 15 May 2025
Synergistic effect and mechanism of meropenem with ciprofloxacin against carbapenem-resistant Acinetobacter baumannii
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1534155
- 1,275 views